<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141651832295000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201903014%26RESULT%3d1%26SIGN%3dt78God16g3bBVnDrhaadT1hz%252bx8%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903014&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903014&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903014&amp;v=MjA4MjNNWmJHNEg5ak1ySTlFWUlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFViN1BQVFg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#40" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#41" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#43" data-title="1.2 方法">1.2 方法</a></li>
                                                <li><a href="#45" data-title="1.3 统计学分析">1.3 统计学分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#48" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#49" data-title="2.1 两组一般临床资料比较">2.1 两组一般临床资料比较</a></li>
                                                <li><a href="#52" data-title="2.2 两组患者的临床诊断分型和冠状动脉造影结果">2.2 两组患者的临床诊断分型和冠状动脉造影结果</a></li>
                                                <li><a href="#55" data-title="2.3 两组随访期间MACCE发生情况比较">2.3 两组随访期间MACCE发生情况比较</a></li>
                                                <li><a href="#61" data-title="2.4 不同治疗方法对患者伴随的心脑血管疾病的关系">2.4 不同治疗方法对患者伴随的心脑血管疾病的关系</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#63" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#51" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组患者临床资料比较&lt;/b&gt;"><b>表</b>1 <b>两组患者临床资料比较</b></a></li>
                                                <li><a href="#54" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组患者临床诊断分型与冠脉造影结果比较&lt;/b&gt;"><b>表</b>2 <b>两组患者临床诊断分型与冠脉造影结果比较</b></a></li>
                                                <li><a href="#57" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;两组随访&lt;/b&gt;30d&lt;b&gt;主要不良心脑血管事件&lt;/b&gt; (MACCE) &lt;b&gt;比较&lt;/b&gt;"><b>表</b>3 <b>两组随访</b>30d<b>主要不良心脑血管事件</b> (MACCE) <b>比较</b></a></li>
                                                <li><a href="#58" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;两组随访&lt;/b&gt;1&lt;b&gt;年&lt;/b&gt;MACCE&lt;b&gt;比较&lt;/b&gt;"><b>表</b>4 <b>两组随访</b>1<b>年</b>MACCE<b>比较</b></a></li>
                                                <li><a href="#59" data-title="&lt;b&gt;表&lt;/b&gt;5 &lt;b&gt;两组随访&lt;/b&gt;2&lt;b&gt;年&lt;/b&gt;MACCE&lt;b&gt;比较&lt;/b&gt;"><b>表</b>5 <b>两组随访</b>2<b>年</b>MACCE<b>比较</b></a></li>
                                                <li><a href="#60" data-title="&lt;b&gt;表&lt;/b&gt;6 &lt;b&gt;两组随访&lt;/b&gt;5&lt;b&gt;年&lt;/b&gt;MACCE&lt;b&gt;比较&lt;/b&gt;"><b>表</b>6 <b>两组随访</b>5<b>年</b>MACCE<b>比较</b></a></li>
                                                <li><a href="#65" data-title="&lt;b&gt;表&lt;/b&gt;7 &lt;b&gt;两组患者&lt;/b&gt;Logistic&lt;b&gt;多因素分析比较&lt;/b&gt;"><b>表</b>7 <b>两组患者</b>Logistic<b>多因素分析比较</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="Cao C, Manganas C, Bannon P, et al.Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease:a meta-analysis of early outcomes from randomized and non-randomized studies[J].J Thorac Cardiovasc Surg, 2013, 145 (3) :738-747." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011600959910&amp;v=MjUwNzF3WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZPZmJLN0h0RE5xWTlGYmU0R0JYMDVvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        Cao C, Manganas C, Bannon P, et al.Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease:a meta-analysis of early outcomes from randomized and non-randomized studies[J].J Thorac Cardiovasc Surg, 2013, 145 (3) :738-747.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Hueb W, Soares PR, Gersh BJ, et al.The medicine, angioplasty, or surgery study (MASS-Ⅱ) :a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease:one-year results[J].J Am Coll Cardiol, 2004, 43 (10) :1743-1751." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100347997&amp;v=MjQ4NzVsVXJmSUlGNFdheFU9TmlmT2ZiSzdIdERPcm85RlorOElCWFUrb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        Hueb W, Soares PR, Gersh BJ, et al.The medicine, angioplasty, or surgery study (MASS-Ⅱ) :a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease:one-year results[J].J Am Coll Cardiol, 2004, 43 (10) :1743-1751.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="Rodriguez AE, Baldi J, Fernandez Pereira C, et al.Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI Ⅱ) [J].J Am Coll Cardiol, 2005, 46 (4) :582-588." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100343949&amp;v=MjEzNDBVcmZJSUY0V2F4VT1OaWZPZmJLN0h0RE9ybzlGWis4TUJYZ3dvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        Rodriguez AE, Baldi J, Fernandez Pereira C, et al.Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI Ⅱ) [J].J Am Coll Cardiol, 2005, 46 (4) :582-588.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="Serruys PW, Ong AT, van Herwerden LA, et al.Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease:the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial[J].J Am Coll Cardiol, 2005, 46 (4) :575-581." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100343948&amp;v=MjU2NzdycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZPZmJLN0h0RE9ybzlGWis4TUJYZ3hvQk1UNlQ0UFFIL2lyUmRHZQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        Serruys PW, Ong AT, van Herwerden LA, et al.Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease:the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial[J].J Am Coll Cardiol, 2005, 46 (4) :575-581.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="Booth J, Clayton T, Pepper J, et al.Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease:six-year follow-up from the Stent or Surgery Trial (SoS) [J].Circulation, 2008, 118 (4) :381-388." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000036292&amp;v=MDU0NzA0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRXYXhVPU5pZmNaYks2SDlIUHI0OUZaT2dKRG5VN29CTVQ2VA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        Booth J, Clayton T, Pepper J, et al.Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease:six-year follow-up from the Stent or Surgery Trial (SoS) [J].Circulation, 2008, 118 (4) :381-388.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Navarese EP, Kubica J, Castriota F, et al.Safety and efficacy of biodegradable vs durable polymer drug-eluting stents:evidence from a meta-analysis of randomized trials[J].EuroIntervention, 2011, 7 (8) :985-994." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials">
                                        <b>[6]</b>
                                        Navarese EP, Kubica J, Castriota F, et al.Safety and efficacy of biodegradable vs durable polymer drug-eluting stents:evidence from a meta-analysis of randomized trials[J].EuroIntervention, 2011, 7 (8) :985-994.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="De Luca G, Dirksen MT, Spaulding C, et al.Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.Drug-eluting vs bare-metal stents in primary angioplasty:a pooled patient-level meta-analysis of randomized trials[J].Arch Intern Med, 2012, 172 (8) :611-621." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty A Pooled Patient-Level Meta-analysis of Randomized Trials">
                                        <b>[7]</b>
                                        De Luca G, Dirksen MT, Spaulding C, et al.Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.Drug-eluting vs bare-metal stents in primary angioplasty:a pooled patient-level meta-analysis of randomized trials[J].Arch Intern Med, 2012, 172 (8) :611-621.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="Stettler C, Wandel S, Allemann S, et al.Outcomes associated with drug-eluting and bare-metal stents:a collaborative network meta-analysis[J].Lancet, 2007, 370 (9591) :937-948." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011600045947&amp;v=MTgyMjF4VT1OaWZPZmJLN0h0RE5xWTlGWk84S0JYZytvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRXYQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        Stettler C, Wandel S, Allemann S, et al.Outcomes associated with drug-eluting and bare-metal stents:a collaborative network meta-analysis[J].Lancet, 2007, 370 (9591) :937-948.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="Carson JL, Scholz PM, Chen AY, et al.Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery[J].J Am Coll Cardiol, 2002, 40 (3) :418-423." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100358245&amp;v=MjA2NTBud1plWnRGaW5sVXJmSUlGNFdheFU9TmlmT2ZiSzdIdERPcm85RlorNEhEbmc4b0JNVDZUNFBRSC9pclJkR2VycVFUTQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        Carson JL, Scholz PM, Chen AY, et al.Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery[J].J Am Coll Cardiol, 2002, 40 (3) :418-423.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="Mercado N, Wijns W, Serruys PW, et al.One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease:A meta analysis of individual patient data from randomized clinicaltrials[J].J Thorac Cardiovasc Surg, 2005, 130 (2) :512-519." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011600969210&amp;v=MTk4ODJNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZPZmJLN0h0RE5xWTlGYmUwR0RuMDVvQg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        Mercado N, Wijns W, Serruys PW, et al.One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease:A meta analysis of individual patient data from randomized clinicaltrials[J].J Thorac Cardiovasc Surg, 2005, 130 (2) :512-519.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="Guyton RA, Coronary artery bypass is superior to drug eluting stents in multivessel coronary artery disease[J].Ann Thorac Surg, 2006, 81 (6) :1949-1957." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease">
                                        <b>[11]</b>
                                        Guyton RA, Coronary artery bypass is superior to drug eluting stents in multivessel coronary artery disease[J].Ann Thorac Surg, 2006, 81 (6) :1949-1957.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="Greenberg D, Bakhai A, Neil N, et al.Modeling the impact of patient and lesion characteristics on the cost-effectiveness of drug eluting stents (abstr) [J].J Am Coll Cardiol, 2003, 41 (Suppl A) :538." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100350800&amp;v=MjY1NDRvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRXYXhVPU5pZk9mYks3SHRET3JvOUZaKzRQQkh3NQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        Greenberg D, Bakhai A, Neil N, et al.Modeling the impact of patient and lesion characteristics on the cost-effectiveness of drug eluting stents (abstr) [J].J Am Coll Cardiol, 2003, 41 (Suppl A) :538.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="Glaser R, Selzer F, Faxon DP, et al.Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention[J].Circulation, 2005, 111 (2) :143-149." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000031749&amp;v=MDM2NDVycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZjWmJLNkg5SFByNDlGWk9nT0MzZ3dvQk1UNlQ0UFFIL2lyUmRHZQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        Glaser R, Selzer F, Faxon DP, et al.Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention[J].Circulation, 2005, 111 (2) :143-149.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="Mack MJ, Osborne JA, Shennib H.Arterial graft patency in coronary artery bypass grafting:what do we really know?[J].Ann Thorac Surg, 1998, 66 (3) :1055-1059." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702053825&amp;v=MDE0NTE4b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZPZmJLN0h0RE5xSTlIWk80TUJINA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        Mack MJ, Osborne JA, Shennib H.Arterial graft patency in coronary artery bypass grafting:what do we really know?[J].Ann Thorac Surg, 1998, 66 (3) :1055-1059.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="Newman MF, Kirchner JL, Phillips-Bute B, et al.Longitudinal assessment of neurocognitive function after coronary artery bypass surgery[J].N Engl J Med, 2001, 344 (6) :395-402." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery">
                                        <b>[15]</b>
                                        Newman MF, Kirchner JL, Phillips-Bute B, et al.Longitudinal assessment of neurocognitive function after coronary artery bypass surgery[J].N Engl J Med, 2001, 344 (6) :395-402.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" title="Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al.Comparative effectiveness of revascularization strategies[J].N Engl J Med, 2012, 366 (16) :1467-1476." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Comparative Effectiveness of Revascularization Strategies">
                                        <b>[16]</b>
                                        Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al.Comparative effectiveness of revascularization strategies[J].N Engl J Med, 2012, 366 (16) :1467-1476.
                                    </a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_17" title="Kappetein AP, Head SJ, Morice MC, et al.Treatment of complex coronary artery disease in patients with diabetes:5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial[J].Eur J Cardiothorac Surg, 2013, 43 (5) :1006-1013." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJOX&amp;filename=SJOX13121300032960&amp;v=MTcyMjc1b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZFZHJLN0g5UE5ySTlGWk9nTkJYbw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[17]</b>
                                        Kappetein AP, Head SJ, Morice MC, et al.Treatment of complex coronary artery disease in patients with diabetes:5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial[J].Eur J Cardiothorac Surg, 2013, 43 (5) :1006-1013.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(03),318-322 DOI:10.3969/j.issn.1008-0074.2019.03.14            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>冠心病多支病变支架植入术与冠脉旁路移植术疗效的比较</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%8E%8B%E6%9C%9D%E9%9C%9E&amp;code=42079050&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">王朝霞</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%8D%A2%E8%8B%B1%E6%B0%91&amp;code=25021285&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">卢英民</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%88%98%E6%B4%AA%E5%BC%BA&amp;code=40909981&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">刘洪强</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BC%A0%E9%87%91%E6%98%A5&amp;code=25817871&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">张金春</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%BB%84%E8%BE%BE%E6%B0%91&amp;code=28228267&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">黄达民</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%BD%97%E6%99%93%E6%B6%B5&amp;code=42079051&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">罗晓涵</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%B2%B3%E5%86%AC%E6%A2%85&amp;code=26933108&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">岳冬梅</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%AD%A3%E4%BF%AD&amp;code=26543374&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">季俭</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%AE%8B%E8%95%BE&amp;code=24134828&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">宋蕾</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9D%8E%E5%BF%97%E5%8D%8E&amp;code=26887414&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">李志华</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BE%90%E4%BC%9F%E5%B9%B3&amp;code=13968954&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">徐伟平</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E4%B8%8A%E6%B5%B7%E4%BA%A4%E9%80%9A%E5%A4%A7%E5%AD%A6%E5%8C%BB%E5%AD%A6%E9%99%A2%E9%99%84%E5%B1%9E%E6%96%B0%E5%8D%8E%E5%8C%BB%E9%99%A2%E5%B4%87%E6%98%8E%E5%88%86%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=0142982&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">上海交通大学医学院附属新华医院崇明分院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨老年冠心病多支冠脉病变患者的雷帕霉素洗脱支架植入术 (SES-PCI) 与冠脉旁路移植术 (CABG) 近期与中期的疗效对比。<b>方法</b>:入选行择期血运重建的多支冠脉病变老年患者, 分为CABG组 (301例) , SES-PCI组 (289例) 。随访30d, 1、2、5年内主要不良心脑血管事件。采用Logistic多元回归, 分析不同治疗方法的独立危险因素。<b>结果</b>:随访30d, 与CABG组比较, SES-PCI组全因死亡率 (6.3%比2.8%) 显著降低, 再次血运重建率 (1.3%比8.3%) 显著升高 (<i>P</i>&lt;0.05或&lt;0.01) ;在1年、2年、5年随访中, 与CABG组比较, SES-PCI组全因死亡率[1年 (11.6%比4.8%) , 5年 (23.3%比12.1%) ]、脑血管意外发生率[1年 (8.6%比3.5%) , 5年 (18.3%比6.9%) ]均显著降低, 非致死性心肌梗死发生率[1年 (6.6%比11.8%) , 5年 (12.0%比24.9%) ]、再次血运重建率[1年 (3.0%比16.3%) , 5年 (9.3%比24.6%) ]均显著升高 (<i>P</i>&lt;0.05或&lt;0.01) 。Logistic多因素回归分析显示, 糖尿病、高血压是SES-PCI治疗的独立危险因素 (OR=45.772、13.218, <i>P</i>均=0.001) , 而周围血管病是SES-PCI治疗的独立保护因素 (OR=0.007, <i>P</i>=0.001) 。<b>结论</b>:与冠脉旁路移植术相比, 多支冠脉病变患者采用支架植入术的近期、中期全因死亡率显著降低, 再次血运重建率显著升高。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89%E7%96%BE%E7%97%85&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冠状动脉疾病;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89%E6%97%81%E8%B7%AF%E7%A7%BB%E6%A4%8D%E6%9C%AF%2C%20%E9%9D%9E%E4%BD%93%E5%A4%96%E5%BE%AA%E7%8E%AF&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冠状动脉旁路移植术, 非体外循环;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E6%94%AF%E6%9E%B6&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">支架;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *徐伟平, E-mail:xuweiping2006@hotmail.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2018-01-18</p>

                    <p>

                            <b>基金：</b>
                                                        <span>上海市科委课题资助 (16411962502);</span>
                    </p>
            </div>
                    <h1>Comparison of therapeutic effect between PCI and CABG on multi-vessel coronary disease</h1>
                    <h2>
                    <span>WANG Zhao-xia</span>
                    <span>LU Ying-min</span>
                    <span>LIU Hong-qiang</span>
                    <span>ZHANG Jin-chun</span>
                    <span>HUANG Da-min</span>
                    <span>LUO Xiao-han</span>
                    <span>YUE Dong-mei</span>
                    <span>JI Jian</span>
                    <span>SONG Lei</span>
                    <span>LI Zhi-hua</span>
                    <span>XU Wei-ping</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Affiliated Xinhua Hospital (Chongming Branch) of Medical University of Shanghai Jiaotong University</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To compare short-term and midterm therapeutic effect between sirolimus-eluting stent implantation (SES-PCI) and coronary artery bypass graft (CABG) in aged patients with coronary heart disease (CHD) and multi-vessel coronary disease (MVD) . <b>Methods</b>:Aged MVD patients undergoing selective revascularization were enrolled and divided into CABG group (n=301) and SES-PCI group (n=289) . Major adverse cardio-and cerebrovascular events (MACCE) were followed up for 30 d, one, two and five years. Logistic multi-factor regression was used to analyze independent risk factors for different therapeutic methods. <b>Results</b>:Compared with CABG group after 30 d follow-up, there was significant reduction in all-cause mortality (6.3% vs. 2.8%) and significant rise in a second revascularization rate (RVR, 1.3% vs. 8.3%) in SES-PCI group, <i>P</i>&lt;0.05 or &lt;0.01; compared with CABG group during one, two and five-year follow up, there were significant reductions in all-cause mortality [one year: (11.6% vs. 4.8%) , five years: (23.3% vs. 12.1%) ]and incidence rate of cerebrovascular accidents [one year: (8.6% vs. 3.5%) , five years: (18.3% vs. 6.9%) ], and significant rise in incidence rate of non-fatal myocardial infarction [one year: (6.6% vs. 11.8%) , five years: (12.0% vs. 24.9%) ]and a second RVR [one year: (3.0% vs. 16.3%) , five years: (9.3% vs. 24.6%) ]in SES-PCI group, <i>P</i>&lt;0.05 or &lt;0.01. Logistic multi-factor regression analysis indicated that DM and EH were independent risk factors for SES-PCI (OR=45.772, 13.218, <i>P</i>=0.001 both) , while peripheral vascular disease was independent protective factor for SES-PCI (OR=0.007, <i>P</i>=0.001) .<b>Conclusion</b>:Compared with CABG, there are significant reductions in short-term and midterm all-cause mortality, and significant rise in a second RVR in MVD patients undergoing PCI.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Coronary%20artery%20disease&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Coronary artery disease;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Coronary%20artery%20bypass%2C%20off-pump&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Coronary artery bypass, off-pump;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Stents&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Stents;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    XU Wei-ping, E-mail: xuweiping2006@hotmail.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2018-01-18</p>
                                    <p>
                            <b>Fund：</b>
                                                        <span>Shanghai Science and Technology Commission Research Project (16411962502);</span>
                    </p>
            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="39">冠状动脉旁路移植术 (CABG) 一直被认为是治疗冠状动脉左主干及多支病变的主要干预手段<citation id="71" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。随着心脏介入医学的发展, 经皮冠状动脉介入治疗 (PCI) 被越来越多地应用于冠状动脉多支病变的患者诊疗过程中。过去的研究表明, CABG和PCI在预防血管狭窄及靶血管再次重建的发生率等方面有显著优势<citation id="72" type="reference"><link href="7" rel="bibliography" /><link href="9" rel="bibliography" /><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><link href="15" rel="bibliography" /><link href="17" rel="bibliography" /><link href="19" rel="bibliography" /><sup>[<a class="sup">2</a>,<a class="sup">3</a>,<a class="sup">4</a>,<a class="sup">5</a>,<a class="sup">6</a>,<a class="sup">7</a>,<a class="sup">8</a>]</sup></citation>, 但以往的研究随访时间短, 多为术后1年, 仅少数提及术后2～5年。因此, CABG与经皮冠状动脉雷帕霉素洗脱支架植入术 (sirolimus-eluting stents percutaneous coronary intervention, SES-PCI) 治疗冠脉多支病变患者的长期疗效尚不明确, 尤其是针对合并糖尿病的患者<citation id="73" type="reference"><link href="21" rel="bibliography" /><link href="23" rel="bibliography" /><link href="25" rel="bibliography" /><sup>[<a class="sup">9</a>,<a class="sup">10</a>,<a class="sup">11</a>]</sup></citation>。 因此, 需重新评价 SES-PCI与CABG对多支病变的治疗效果。本研究观察冠脉多支病变患者行SES-PCI的近、中期治疗效果, 并与 CABG 进行对比。</p>
                </div>
                <h3 id="40" name="40" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="41" name="41">1.1 一般资料</h4>
                <div class="p1">
                    <p id="42">选择2013年1月至 2014年 1月直接到本院就诊或社区医院转诊来我院年龄大于60岁的老年冠心病患者90例。根据血运重建方式的不同分为CABG 组 (301例) 和SES-PCI组 (289例) 。入选患者的冠状动脉造影显示冠状动脉至少有2处病变, 或有左主干病变, 病变直径狭窄≥ 50%。排除急性心肌梗塞行直接支架术、既往行CABG、或CABG与其它心脏外科手术同期进行的患者。</p>
                </div>
                <h4 class="anchor-tag" id="43" name="43">1.2 方法</h4>
                <div class="p1">
                    <p id="44">所有患者行相关冠心病影像学检测后, 行诊断性冠脉造影术, 最后按照术前危险度进行评估。排除冠心病中的急性ST段抬高型心肌梗死、非ST段抬高型心肌梗死及合并严重心、脑血管并发症患者。对于符合复杂冠心病的诊断标准, SYNTAX评分分布于中分区 (23～32分) 及高分区 (≥33分) , 患者及其家属愿意接受有关微创治疗手段, 在常规药物治疗基础上行SES-PCI术或CABG术, 术后常规强化抗血小板、调脂治疗等处理, 同时加强冠心病的二级预防及相关并发症的预防及治疗。临床终点包括以下主要心脑血管不良事件 (MACCE) :总死亡、卒中、非致死性心肌梗塞和再次血运重建。出院后的随访主要采用电话询问。</p>
                </div>
                <h4 class="anchor-tag" id="45" name="45">1.3 统计学分析</h4>
                <div class="p1">
                    <p id="46">采用SPSS 13.0数据库软件进行数据分析。计量资料以均数±标准差<mathml id="47"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml>表示, 两组间比较采用<i>t</i>检验。计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。 当四格表中有小于1的数据时, 采用Fisher 精确概率检验。采用 Logistic 多元回归进行多因素分析。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="48" name="48" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="49" name="49">2.1 两组一般临床资料比较</h4>
                <div class="p1">
                    <p id="50">CABG组中85.9%的患者使用了乳内动脉。SES-PCI组中50.2%的患者植入≥ 2个支架。与CABG组比较, SES-PCI组糖尿病、血管重建比例显著增加, 陈旧性心梗、周围血管病比较显著减少 (<i>P</i>&lt;0.05或&lt;0.01) 。见表1。</p>
                </div>
                <div class="area_img" id="51">
                    <p class="img_tit"><b>表</b>1 <b>两组患者临床资料比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="51" border="1"><tr><td><br /></td><td>CABG组<br /> (301例) </td><td>SES-PCI组<br /> (289例) </td><td><i>t</i>/<i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />年龄 (岁) </td><td>72.3±5.2</td><td>72.9±4.7</td><td>1.445</td><td>0.149</td></tr><tr><td><br />男性<i>n</i> (%) </td><td>212 (70.4) </td><td>199 (68.9) </td><td>0.173</td><td>0.678</td></tr><tr><td><br />冠心病家族史<i>n</i> (%) </td><td>8 (2.7) </td><td>6 (2.1) </td><td>0.215</td><td>0.643</td></tr><tr><td><br />吸烟史<i>n</i> (%) </td><td>188 (62.5) </td><td>194 (67.1) </td><td>1.408</td><td>0.235</td></tr><tr><td><br />人体质量指数 (kg/m<sup>2</sup>) </td><td>21.9±3.8</td><td>22.4±3.9</td><td>-1.471</td><td>0.142</td></tr><tr><td><br />糖尿病<i>n</i> (%) </td><td>63 (20.9) </td><td>86 (29.8) <sup>△</sup></td><td>6.087</td><td>0.014</td></tr><tr><td><br />高血压<i>n</i> (%) </td><td>168 (55.8) </td><td>185 (64.0) </td><td>4.125</td><td>0.042</td></tr><tr><td><br />脑血管病史<i>n</i> (%) </td><td>23 (7.6) </td><td>20 (6.9) </td><td>0.113</td><td>0.736</td></tr><tr><td><br />瓣膜病<i>n</i> (%) </td><td>2 (0.7) </td><td>1 (0.4) </td><td>0.001</td><td>1.001</td></tr><tr><td><br />陈旧性心梗<i>n</i> (%) </td><td>136 (45.2) </td><td>95 (32.9) <sup>△△</sup></td><td>9.379</td><td>0.002</td></tr><tr><td><br />血管重建史<i>n</i> (%) </td><td>11 (3.7) </td><td>44 (15.2) <sup>△△</sup></td><td>23.351</td><td>0.001</td></tr><tr><td><br />肾病史<i>n</i> (%) </td><td>2 (0.7) </td><td>3 (1.0) </td><td>0.002</td><td>0.964</td></tr><tr><td><br />周围血管病<i>n</i> (%) </td><td>211 (70.1) </td><td>95 (32.9) <sup>△△</sup></td><td>81.848</td><td>0.001</td></tr><tr><td><br />慢阻肺<i>n</i> (%) </td><td>2 (0.7) </td><td>8 (2.8) </td><td>2.755</td><td>0.097</td></tr><tr><td><br />肌酐 (μmol/L) </td><td>86.0±5.1</td><td>85.3±5.7</td><td>1.628</td><td>0.104</td></tr><tr><td><br />血红蛋白 (g/L) </td><td>115.6±5.8</td><td>116.5±6.3</td><td>-1.743</td><td>0.082</td></tr><tr><td><br />HDL-C (mmol/L) </td><td>1.1±0.2</td><td>1.2±0.2</td><td>-1.833</td><td>0.067</td></tr><tr><td><br />LDL-C (mmol/L) </td><td>2.5±0.6</td><td>2.6±0.6</td><td>-1.571</td><td>0.117</td></tr><tr><td><br />左心功能不全<i>n</i> (%) </td><td>5 (1.7) </td><td>4 (1.4) </td><td>0.001</td><td>1.001</td></tr><tr><td><br />左室射血分数 (%) </td><td>55.1±3.4</td><td>54.7±3.2</td><td>1.595</td><td>0.111</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:HDL-C:高密度脂蛋白-胆固醇, LDL-C:低密度脂蛋白-胆固醇。CABG组:冠状动脉旁路移植术组, SES-PCI组:雷帕霉素洗脱支架植入术组。与CABG组比较△ <i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="52" name="52">2.2 两组患者的临床诊断分型和冠状动脉造影结果</h4>
                <div class="p1">
                    <p id="53">与CABG组比较, SES-PCI组中不稳定型心绞痛、3支病变、前降支近段病变、慢性完全闭塞病变比例显著减小 (<i>P</i>均=0.001) , 但两组冠脉SYNTAX评分无差异。见表2。</p>
                </div>
                <div class="area_img" id="54">
                    <p class="img_tit"><b>表</b>2 <b>两组患者临床诊断分型与冠脉造影结果比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="54" border="1"><tr><td><br /></td><td>CABG组<br /> (301例) </td><td>SES-PCI组<br /> (289例) </td><td><i>t</i>/<i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />不稳定型心绞痛<i>n</i> (%) </td><td>236 (78.4) </td><td>191 (66.1) <sup>△△</sup></td><td>11.184</td><td>0.001</td></tr><tr><td><br />稳定型心绞痛<i>n</i> (%) </td><td>65 (21.6) </td><td>98 (33.9) <sup>△△</sup></td><td>11.184</td><td>0.001</td></tr><tr><td><br />2支病变<i>n</i> (%) </td><td>62 (20.6) </td><td>94 (32.5) <sup>△△</sup></td><td>10.785</td><td>0.001</td></tr><tr><td><br />3支病变<i>n</i> (%) </td><td>239 (79.4) </td><td>195 (67.5) <sup>△△</sup></td><td>10.785</td><td>0.001</td></tr><tr><td><br />左前降支近段病变<i>n</i> (%) </td><td>187 (62.1) </td><td>96 (33.2) <sup>△△</sup></td><td>49.367</td><td>0.001</td></tr><tr><td><br />左主干病变<i>n</i> (%) </td><td>37 (12.3) </td><td>38 (13.1) </td><td>0.097</td><td>0.755</td></tr><tr><td><br />慢性完全闭塞病变<i>n</i> (%) </td><td>172 (57.1) </td><td>99 (34.3) <sup>△△</sup></td><td>31.098</td><td>0.001</td></tr><tr><td><br />支架内再狭窄<i>n</i> (%) </td><td>6 (2.0) </td><td>17 (5.9) <sup>△</sup></td><td>5.952</td><td>0.015</td></tr><tr><td><br />SYNTAX评分</td><td>36.2±3.6</td><td>35.7±3.7</td><td>1.787</td><td>0.074</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="55" name="55">2.3 两组随访期间MACCE发生情况比较</h4>
                <div class="p1">
                    <p id="56">随访30d, 与CABG组比较, SES-PCI组全因死亡率 (6.3%比2.8%) 显著降低, 再次血运重建率 (1.3%比8.3%) 显著升高 (<i>P</i>&lt;0.05或&lt;0.01) ;在1年、2年、5年随访中, 与CABG组比较, SES-PCI组全因死亡率、脑血管意外发生率均显著降低, 非致死性心肌梗死发生率、再次血运重建率均显著升高 (<i>P</i>&lt;0.05或&lt;0.01) 。见表3～6。</p>
                </div>
                <div class="area_img" id="57">
                    <p class="img_tit"><b>表</b>3 <b>两组随访</b>30d<b>主要不良心脑血管事件</b> (MACCE) <b>比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="57" border="1"><tr><td><br /></td><td>CABG组<br /> (301例) </td><td>SES-PCI组<br /> (289例) </td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />全因性死亡<i>n</i> (%) </td><td>19 (6.3) </td><td>8 (2.8) <sup>△</sup></td><td>4.241</td><td>0.039</td></tr><tr><td><br />脑血管意外 <i>n</i> (%) </td><td>12 (4.0) </td><td>5 (1.7) </td><td>2.683</td><td>0.101</td></tr><tr><td><br />非致死性心肌梗死<i>n</i> (%) </td><td>9 (3.0) </td><td>17 (5.9) </td><td>2.928</td><td>0.087</td></tr><tr><td><br />再次血运重建<i>n</i> (%) </td><td>4 (1.3) </td><td>24 (8.3) <sup>△△</sup></td><td>15.870</td><td>0.001</td></tr><tr><td><br />MACCE合计<i>n</i> (%) </td><td>24 (7.9) </td><td>28 (9.7) </td><td>0.540</td><td>0.463</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="58">
                    <p class="img_tit"><b>表</b>4 <b>两组随访</b>1<b>年</b>MACCE<b>比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="58" border="1"><tr><td><br /></td><td>CABG组<br /> (301例) </td><td>SES-PCI组<br /> (289例) </td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />全因性死亡<i>n</i> (%) </td><td>35 (11.6) </td><td>14 (4.8) <sup>△△</sup></td><td>8.909</td><td>0.003</td></tr><tr><td><br />脑血管意外 <i>n</i> (%) </td><td>26 (8.6) </td><td>10 (3.5) <sup>△△</sup></td><td>6.899</td><td>0.009</td></tr><tr><td><br />非致死性心肌梗死<i>n</i> (%) </td><td>20 (6.6) </td><td>34 (11.8) <sup>△</sup></td><td>4.649</td><td>0.031</td></tr><tr><td><br />再次血运重建<i>n</i> (%) </td><td>9 (3.0) </td><td>47 (16.3) <sup>△△</sup></td><td>30.236</td><td>0.001</td></tr><tr><td><br />MACCE合计<i>n</i> (%) </td><td>54 (17.9) </td><td>58 (20.1) </td><td>0.435</td><td>0.510</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="59">
                    <p class="img_tit"><b>表</b>5 <b>两组随访</b>2<b>年</b>MACCE<b>比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="59" border="1"><tr><td><br /></td><td>CABG组<br /> (301例) </td><td>SES-PCI组<br /> (289例) </td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />全因性死亡<i>n</i> (%) </td><td>53 (17.6) </td><td>21 (7.3) <sup>△△</sup></td><td>14.375</td><td>0.001</td></tr><tr><td><br />脑血管意外 <i>n</i> (%) </td><td>41 (13.6) </td><td>15 (5.2) <sup>△△</sup></td><td>12.199</td><td>0.001</td></tr><tr><td><br />非致死性心肌梗死<i>n</i> (%) </td><td>28 (9.3) </td><td>53 (18.3) <sup>△△</sup></td><td>10.166</td><td>0.001</td></tr><tr><td><br />再次血运重建<i>n</i> (%) </td><td>14 (4.7) </td><td>64 (22.1) <sup>△△</sup></td><td>39.331</td><td>0.001</td></tr><tr><td><br />MACCE合计<i>n</i> (%) </td><td>72 (23.9) </td><td>78 (27.0) </td><td>0.733</td><td>0.392</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="60">
                    <p class="img_tit"><b>表</b>6 <b>两组随访</b>5<b>年</b>MACCE<b>比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="60" border="1"><tr><td><br /></td><td>CABG组<br /> (301例) </td><td>SES-PCI组<br /> (289例) </td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />全因性死亡<i>n</i> (%) </td><td>70 (23.3) </td><td>35 (12.1) <sup>△△</sup></td><td>12.518</td><td>0.001</td></tr><tr><td><br />脑血管意外 <i>n</i> (%) </td><td>55 (18.3) </td><td>20 (6.9) <sup>△△</sup></td><td>17.124</td><td>0.001</td></tr><tr><td><br />非致死性心肌梗死<i>n</i> (%) </td><td>36 (12.0) </td><td>72 (24.9) <sup>△△</sup></td><td>16.543</td><td>0.001</td></tr><tr><td><br />再次血运重建<i>n</i> (%) </td><td>28 (9.3) </td><td>71 (24.6) <sup>△△</sup></td><td>24.604</td><td>0.001</td></tr><tr><td><br />MACCE合计<i>n</i> (%) </td><td>99 (32.9) </td><td>93 (32.7) </td><td>0.001</td><td>0.970</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="61" name="61">2.4 不同治疗方法对患者伴随的心脑血管疾病的关系</h4>
                <div class="p1">
                    <p id="62">采用Logistic多因素回归分析, 以因变量CABG治疗赋值为0, SES-PCI治疗赋值为1。选取一般资料中有差异的变量为自变量, 包括糖尿病、高血压、陈旧性心梗、血管重建史、周围血管病和慢阻肺。结果表明糖尿病、高血压是SES-PCI治疗的独立危险因素 (OR=45.772、13.218, <i>P</i>均=0.001) , 周围血管病是SES-PCI治疗的保护因素 (OR=0.007, <i>P</i>=0.001) , 患有周围血管病的患者, 更多选择了CABG治疗。见表7。</p>
                </div>
                <h3 id="63" name="63" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="64">最新研究表明, 对于稳定型心绞痛患者, PCI与药物治疗比较, 并不降低死亡率、心肌梗塞发生率或其他主要心血管事件的发生率。 CABG治疗冠心病2或3支病变的长期效果优于植入BMS, 动脉再血管化治疗研究 (ARTS) 、冠脉介入术后再狭窄与低分子量肝素研究 (ERACI II) 和血管成形术或外科手术的综合分析 (MASS) II 3个 随机临床研究的荟萃分析显示, CABG 相比于BMS植入的唯一优势是血运重建率低<citation id="74" type="reference"><link href="27" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>。Glaser R<citation id="75" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>比较了CABG 治疗和PCI治疗患者术后3年死亡率, CABG治疗组显著低于支架治疗组。</p>
                </div>
                <div class="area_img" id="65">
                    <p class="img_tit"><b>表</b>7 <b>两组患者</b>Logistic<b>多因素分析比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="65" border="1"><tr><td><br /></td><td>β</td><td>S.E.</td><td>Wald <i>χ</i><sup>2</sup></td><td>OR</td><td>95% 可信区间</td><td><i>P</i></td></tr><tr><td><br />糖尿病</td><td>3.824</td><td>0.456</td><td>70.410</td><td>45.772</td><td>18.738～111.808</td><td>0.001</td></tr><tr><td><br />高血压</td><td>2.582</td><td>0.355</td><td>52.920</td><td>13.218</td><td>6.593～26.500</td><td>0.001</td></tr><tr><td><br />陈旧性心梗</td><td>-0.599</td><td>0.427</td><td>1.966</td><td>0.550</td><td>0.238～1.269</td><td>0.161</td></tr><tr><td><br />血管重建史</td><td>0.381</td><td>0.431</td><td>0.783</td><td>1.464</td><td>0.629～3.407</td><td>0.376</td></tr><tr><td><br />周围血管病</td><td>-4.970</td><td>0.460</td><td>116.703</td><td>0.007</td><td>0.003～0.017</td><td>0.001</td></tr><tr><td><br />慢阻肺</td><td>1.327</td><td>0.805</td><td>2.719</td><td>3.771</td><td>0.779～18.265</td><td>0.099</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="p1">
                    <p id="66">研究显示, 与BMS相比, 对于简单冠脉病变、部分复杂病变及糖尿病患者, SES的应用使再狭窄率和再次血运重建率显著下降, 由此推论, 对于多支冠状动脉病变, SES 植入即使不优CABG, 也可能与CABG等效。本研究对象是老年多支病变患者, 比较采用择期 CABG或 SES-PCI植入的临床疗效。本研究随访结果提示, SES-PCI组死亡率低于CABG组, 但是再次血运重建率显著升高。</p>
                </div>
                <div class="p1">
                    <p id="67">本研究老年冠脉多支病变SES组再次血运重建率高于 CABG, 可能与下述因素有关。一是本研究再次 PCI 的定义与先前报道的随机研究不同。本研究的再次PCI不但包括既往曾行支架术的靶血管和靶病变, 也包括未曾植入过支架的血管因病变进展而行PCI。美国国立心肺血液研究所的一项注册研究分析了PCI后1年, 非靶病变的进展情况, 结果显示有6%的先前认为无需介入干预的病变因进展需行 PCI。该资料提示广泛严重的冠心病 PCI 的结果最差。</p>
                </div>
                <div class="p1">
                    <p id="68">本研究结果显示:与SES-PCI组相比, CABG可显著降低冠脉多支病变患者术后1年、2年、5年的靶血管再次血运重建率、心肌梗死发生率, 其机制可能包括:① CABG中使用左乳内动脉桥血管, 可提供较好的长期通畅率和减少术后死亡人数, Mack等<citation id="76" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>研究也显示左乳内动脉具有较好的远期通畅率, 且前降支吻合术后10年通畅率&gt;90%;② CABG可最大限度地实现术中靶血管的完全再血管化。但是, 1年、2年及5年随访中CABG组均显著增加了脑卒中的发生率, 考虑可能与术中应用体外循环增加了动脉粥样硬化斑块的栓塞及其引起的全身性炎症反应对后期脏器功能的影响有关, 但Newman等<citation id="77" type="reference"><link href="33" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>的前瞻性研究提示CABG术后5年会有42%的患者出现轻度认知功能障碍, 因此采取策略使用非体外循环下或主动脉无接触技术行CABG可能会降低术后脑卒中的发生率。</p>
                </div>
                <div class="p1">
                    <p id="69">本研究Logistic多因素分析发现, 伴有糖尿病或高血压的患者是选择进行SES-PCI治疗的独立危险因素, 而患有周围血管病的患者, 由于其外周血管病变的复杂性, 更多的研究对象选择了CABG治疗。众所周知, 高血压是引起冠心病的传统危险因素, 而近年来糖尿病与冠心病发生的相关性受到更多的关注。糖尿病患者冠心病的发病率比非糖尿病高2～5倍, 心血管死亡是非糖尿病的2～4倍, 因此糖尿病患者往往存在多支冠状动脉血管严重病变。目前对于冠状动脉多支病变合并糖尿病的治疗策略选择尚存争议。Weitraub等<citation id="78" type="reference"><link href="35" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>的研究表明, 糖尿病患者随访1年, CABG组与SES-PCI组的病死率无明显差异, 随访4年SES-PCI组的病死率明显高于CABG组。Kappetein等<citation id="79" type="reference"><link href="37" rel="bibliography" /><sup>[<a class="sup">17</a>]</sup></citation>的研究则表明糖尿病患者随访5年两组的心脑血管事件发生率无明显差异。本研究Logistic多因素分析分析的结果显示:对于合并糖尿病多支病变的患者, 更多的患者选择SES-PCI治疗方法。同时本研究患者中远期的随访时我们发现, 无论术后1年、2年还是5年, CABG组脑卒中发生率均明显高于对照组;但非致死性心肌梗死的发生率, 术后1年、2年和5年CABG组更低, 考虑可能一方面与糖尿病患者SES-PCI引发的内膜生物学效应有关, 另一方面与SES-PCI冠状动脉的完全血运重建率较低有关。</p>
                </div>
                <div class="p1">
                    <p id="70">总之, 通过本研究我们发现与冠脉旁路移植术相比, 多支冠脉病变患者采用支架植入术的近期全因死亡率显著降低, 再次血运重建率显著升高, 中期全因死亡和脑血管意外发生率显著降低, 非致死性心梗和再次血运重建发生率显著升高。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011600959910&amp;v=MTIwNjNUNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRXYXhVPU5pZk9mYks3SHRETnFZOUZiZTRHQlgwNW9CTQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>Cao C, Manganas C, Bannon P, et al.Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease:a meta-analysis of early outcomes from randomized and non-randomized studies[J].J Thorac Cardiovasc Surg, 2013, 145 (3) :738-747.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100347997&amp;v=MDMxMjc9TmlmT2ZiSzdIdERPcm85RlorOElCWFUrb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>Hueb W, Soares PR, Gersh BJ, et al.The medicine, angioplasty, or surgery study (MASS-Ⅱ) :a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease:one-year results[J].J Am Coll Cardiol, 2004, 43 (10) :1743-1751.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100343949&amp;v=MTAwMjBvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRXYXhVPU5pZk9mYks3SHRET3JvOUZaKzhNQlhndw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>Rodriguez AE, Baldi J, Fernandez Pereira C, et al.Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI Ⅱ) [J].J Am Coll Cardiol, 2005, 46 (4) :582-588.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100343948&amp;v=MTczOTVsVXJmSUlGNFdheFU9TmlmT2ZiSzdIdERPcm85RlorOE1CWGd4b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>Serruys PW, Ong AT, van Herwerden LA, et al.Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease:the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial[J].J Am Coll Cardiol, 2005, 46 (4) :575-581.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000036292&amp;v=MjI1NzhmY1piSzZIOUhQcjQ5RlpPZ0pEblU3b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>Booth J, Clayton T, Pepper J, et al.Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease:six-year follow-up from the Stent or Surgery Trial (SoS) [J].Circulation, 2008, 118 (4) :381-388.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials">

                                <b>[6]</b>Navarese EP, Kubica J, Castriota F, et al.Safety and efficacy of biodegradable vs durable polymer drug-eluting stents:evidence from a meta-analysis of randomized trials[J].EuroIntervention, 2011, 7 (8) :985-994.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty A Pooled Patient-Level Meta-analysis of Randomized Trials">

                                <b>[7]</b>De Luca G, Dirksen MT, Spaulding C, et al.Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.Drug-eluting vs bare-metal stents in primary angioplasty:a pooled patient-level meta-analysis of randomized trials[J].Arch Intern Med, 2012, 172 (8) :611-621.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011600045947&amp;v=MDAyODRxWTlGWk84S0JYZytvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRXYXhVPU5pZk9mYks3SHRETg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>Stettler C, Wandel S, Allemann S, et al.Outcomes associated with drug-eluting and bare-metal stents:a collaborative network meta-analysis[J].Lancet, 2007, 370 (9591) :937-948.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100358245&amp;v=MDkzMDVyZklJRjRXYXhVPU5pZk9mYks3SHRET3JvOUZaKzRIRG5nOG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>Carson JL, Scholz PM, Chen AY, et al.Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery[J].J Am Coll Cardiol, 2002, 40 (3) :418-423.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011600969210&amp;v=MTMyODM1b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZPZmJLN0h0RE5xWTlGYmUwR0RuMA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>Mercado N, Wijns W, Serruys PW, et al.One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease:A meta analysis of individual patient data from randomized clinicaltrials[J].J Thorac Cardiovasc Surg, 2005, 130 (2) :512-519.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease">

                                <b>[11]</b>Guyton RA, Coronary artery bypass is superior to drug eluting stents in multivessel coronary artery disease[J].Ann Thorac Surg, 2006, 81 (6) :1949-1957.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100350800&amp;v=MjQ1NjdQQkh3NW9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGNFdheFU9TmlmT2ZiSzdIdERPcm85RlorNA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>Greenberg D, Bakhai A, Neil N, et al.Modeling the impact of patient and lesion characteristics on the cost-effectiveness of drug eluting stents (abstr) [J].J Am Coll Cardiol, 2003, 41 (Suppl A) :538.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000031749&amp;v=MTQ0MTZOaWZjWmJLNkg5SFByNDlGWk9nT0MzZ3dvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRXYXhVPQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>Glaser R, Selzer F, Faxon DP, et al.Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention[J].Circulation, 2005, 111 (2) :143-149.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702053825&amp;v=MDQ5ODFPNE1CSDQ4b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZPZmJLN0h0RE5xSTlIWg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>Mack MJ, Osborne JA, Shennib H.Arterial graft patency in coronary artery bypass grafting:what do we really know?[J].Ann Thorac Surg, 1998, 66 (3) :1055-1059.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery">

                                <b>[15]</b>Newman MF, Kirchner JL, Phillips-Bute B, et al.Longitudinal assessment of neurocognitive function after coronary artery bypass surgery[J].N Engl J Med, 2001, 344 (6) :395-402.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Comparative Effectiveness of Revascularization Strategies">

                                <b>[16]</b>Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al.Comparative effectiveness of revascularization strategies[J].N Engl J Med, 2012, 366 (16) :1467-1476.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_17" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJOX&amp;filename=SJOX13121300032960&amp;v=MTAxNTU1b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0V2F4VT1OaWZFZHJLN0g5UE5ySTlGWk9nTkJYbw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[17]</b>Kappetein AP, Head SJ, Morice MC, et al.Treatment of complex coronary artery disease in patients with diabetes:5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial[J].Eur J Cardiothorac Surg, 2013, 43 (5) :1006-1013.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201903014" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903014&amp;v=MjA4MjNNWmJHNEg5ak1ySTlFWUlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFViN1BQVFg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
